New technology fuses MRI, ultrasound to achieve targeted biopsy of prostate cancer

Targeted biopsy, a major advance in prostate cancer diagnostics, was detailed by a UCLA team in the current issue of Urologic Oncology. The new technology fuses MRI with real-time 3D ultrasound, providing an exacting method to obtain biopsy specimens from suspicious areas in the prostate.

Read the whole article on Physorg

More from Physorg